Epoch Investment Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,464
Closed -$709K 294
2024
Q3
$709K Sell
8,464
-152
-2% -$12K ﹤0.01% 322
2024
Q2
$664K Buy
8,616
+840
+11% +$61.5K ﹤0.01% 332
2024
Q1
$533K Sell
7,776
-1,381
-15% -$88.8K ﹤0.01% 368
2023
Q4
$529K Sell
9,157
-2,000
-18% -$107K ﹤0.01% 375
2023
Q3
$589K Sell
11,157
-2,393
-18% -$126K ﹤0.01% 375
2023
Q2
$733K Sell
13,550
-803,774
-98% -$42M ﹤0.01% 383
2023
Q1
$40.9M Sell
817,324
-227,336
-22% -$10.7M 0.24% 142
2022
Q4
$48.3M Buy
1,044,660
+105,202
+11% +$4.56M 0.29% 118
2022
Q3
$36.4M Buy
939,458
+134,013
+17% +$5.38M 0.24% 145
2022
Q2
$30M Buy
805,445
+5,196
+0.6% +$212K 0.18% 171
2022
Q1
$35.4M Buy
800,249
+125,812
+19% +$5.45M 0.17% 168
2021
Q4
$28.6M Buy
+674,437
New +$28.3M 0.15% 180
2020
Q4
Sell
-1,870,648
Closed -$71.5M 326
2020
Q3
$71.5M Sell
1,870,648
-598,590
-24% -$23.1M 0.36% 104
2020
Q2
$86.7M Sell
2,469,238
-150,912
-6% -$5.43M 0.45% 80
2020
Q1
$85.5M Sell
2,620,150
-346,476
-12% -$13.5M 0.52% 70
2019
Q4
$134M Sell
2,966,626
-382,734
-11% -$16M 0.58% 64
2019
Q3
$136M Sell
3,349,360
-847,711
-20% -$35.9M 0.62% 59
2019
Q2
$180M Sell
4,197,071
-229,438
-5% -$8.82M 0.81% 39
2019
Q1
$170M Sell
4,426,509
-146,035
-3% -$5.58M 0.74% 45
2018
Q4
$162M Sell
4,572,544
-394,031
-8% -$14.3M 0.75% 42
2018
Q3
$191M Buy
4,966,575
+1,417,256
+40% +$49.5M 0.73% 42
2018
Q2
$116K Buy
+3,549,319
New +$107M 0.36% 86

Other funds holding BSX

Epoch Investment Partners's BSX Position: Q4 2024 in Review

Epoch Investment Partners sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 8,464 shares — an estimated $709K sold.

Epoch Investment Partners first reported a position in BSX in Q2 2018 and held it in 22 quarters. The position peaked at $191M in Q3 2018. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Epoch Investment Partners reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Epoch Investment Partners sold 8,464 Boston Scientific shares in Q4 2024, an estimated $709K.
  • Epoch Investment Partners first reported a position in Boston Scientific in Q2 2018 and held it in 22 quarters.
  • Epoch Investment Partners's Boston Scientific position peaked at $191M in Q3 2018.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Epoch Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.